Viewing Eye Care Network

Surgery

Latest News


CME Content


April 15 marked the 10-year anniversary of FDA approval of onabotulinumtoxinA (Botox Cosmetic, Allergan) to help improve the look of moderate to severe frown lines between the eyebrows in patients aged 18 to 65 years.